AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Momenta PharmaceuticalsAdaptive BiotechnologiesAblynxIovance BiotherapeuticsAudentes Therapeutics
SymbolNASDAQ:MNTANASDAQ:ADPTOTCMKTS:ABLYFNASDAQ:IOVANASDAQ:BOLD
Price Information
Current Price$30.98$39.07$50.63$33.12$59.97
52 Week RangeBuyBuyN/ABuyHold
Beat the Market™ Rank
Overall Score1.21.30.41.70.9
Analysis Score2.42.40.04.51.1
Community Score2.52.42.23.22.6
Dividend Score0.00.00.00.00.0
Ownership Score1.01.00.01.01.0
Earnings & Valuation Score0.00.60.00.00.0
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyHold
Consensus Price Target$38.13$43.60N/A$42.36$50.75
% Upside from Price Target23.06% upside11.59% upsideN/A27.89% upside-15.37% downside
Trade Information
Market Cap$3.71 billion$4.91 billion$3.81 billion$4.07 billion$2.77 billion
Beta1.47N/A1.991.172.18
Average Volume945,2111,046,740N/A2,113,6821,504,389
Sales & Book Value
Annual Revenue$23.87 million$85.07 million$62.73 millionN/AN/A
Price / Sales152.7758.2860.74N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$4.59 per share$4.59 per share$2.71 per share$2.37 per share($7.48) per share
Price / Book6.758.5118.68N/AN/A
Profitability
Net Income$-290,050,000.00$-68,610,000.00$-122,670,000.00$-197,560,000.00$-128,820,000.00
EPS($3.03)($1.01)N/A($1.59)($3.40)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-994.16%-87.47%N/AN/AN/A
Return on Equity (ROE)-80.37%-22.92%N/A-71.12%N/A
Return on Assets (ROA)-57.27%-9.88%N/A-62.87%-38.00%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/A0.01%N/A
Current Ratio5.90%7.50%N/A6.48%12.80%
Quick Ratio5.90%7.37%N/A6.48%12.79%
Ownership Information
Institutional Ownership Percentage96.29%76.23%N/A95.98%96.33%
Insider Ownership Percentage2.60%22.20%N/A9.30%5.30%
Miscellaneous
Employees131346N/A88207
Shares Outstanding117.71 million126.89 million75.25 million126.86 million46.27 million
Next Earnings Date8/7/2020 (Estimated)8/11/2020 (Estimated)N/A8/6/2020 (Estimated)N/A
OptionableOptionableNot OptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.